Patent US5091309A successfully refreshed from Google Patents.
US5091309A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sindbis virus vectors
Assignee: Washington University in St. Louis
•
Filing: 1989-08-17
•
Granted: 1992-02-25
•
Expires: 2009-08-17
Abstract
Abstract The present invention relates to RNA vectors comprising Sindbis virus DI RNA having inserted therein heterologous RNA. The vectors of the present invention provide for the cloning and expression of heterologous RNA in eucaryotic cells as well as the packaging of heterologous RNA into viral particles in the presence of helper virus. Transformed cells and genetically altered alphavirus particles comprising alphavirus DI RNA having inserted therein heterologous RNA are also provided.
Inventors
- 👤 Sondra Schlesinger
- 👤 Henry V. Huang
- 👤 Robin Levis
- 👤 Barbara Weiss
- 👤 Manuel Tsiang
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 13:34
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; C12N2770/00; C12N2770/00011; C12N2770/36011; C12N2770/36111; C12N2770/36122; C12N2770/36141; C12N2770/36143; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
40 words
A RNA vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, an RNA sequence complementary to a restriction endonuclease site, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 2
Dependent Claim
40 words
A RNA vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, an RNA sequence complementary to a restriction endonuclease site, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 3
Dependent Claim
21 words
The vector of claim 1 additionally comprising a heterologous RNA sequence complementary to a DNA sequence inserted at the restriction site.
Claim 4
Dependent Claim
23 words
Essentially pure Sindbis virus DI RNA consisting essentially of nucleotides 1 to 241 and 1928 to 2314, followed by a poly A tail.
Claim 5
Dependent Claim
23 words
Essentially pure Sindbis virus DI RNA consisting essentially of nucleotides 1 to 241 and 1928 to 2314, followed by a poly A tail.
Claim 6
Dependent Claim
57 words
An expression vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon followed by RNA sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 7
Dependent Claim
57 words
An expression vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon followed by RNA sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 8
Dependent Claim
60 words
A genetically altered eucaryotic cell containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon followed by RNA-sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 9
Dependent Claim
60 words
A genetically altered eucaryotic cell containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon followed by RNA-sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 10
Dependent Claim
62 words
A genetically altered Sindbis virus DI particle containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon, followed by RNA-sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 11
Dependent Claim
62 words
A genetically altered Sindbis virus DI particle containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon, followed by RNA-sequences encoding a protein or fragment thereof to be expressed, followed by a translation termination codon, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail.
Claim 12
Independent Claim
108 words
A method of replicating heterologous RNA in eucaryotic cells comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising a heterologous DNA between nucleotides 241 and 1928 to create a chimeric DNA; c. transcribing the chimeric DNA into chimeric RNA; d. transfecting the eucaryotic cell with the chimeric RNA in the presence of helper virus; and e. growing the transfected eucaryotic cells under conditions which promote replication of Sindbis virus DI RNA.
Claim 13
Independent Claim
108 words
A method of replicating heterologous RNA in eucaryotic cells comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising a heterologous DNA between nucleotides 241 and 1928 to create a chimeric DNA; c. transcribing the chimeric DNA into chimeric RNA; d. transfecting the eucaryotic cell with the chimeric RNA in the presence of helper virus; and e. growing the transfected eucaryotic cells under conditions which promote replication of Sindbis virus DI RNA.
Claim 14
Independent Claim
86 words
A method of replicating a heterologous RNA in a eucaryotic cell comprising the steps of: a. isolating plasmid KDI-25 from an E. coli culture having ATCC accession number 53426; b. inserting heterologous DNA into the BalI site of plasmid KDI-25 to create a chimeric plasmid, c. transcribing the chimeric plasmid, into chimeric RNA; d. transfecting a eucaryotic cell with the chimeric RNA in the presence of helper virus; and e. growing the transfected eucaryotic cells under conditions which promote the replication of Sindbis virus DI RNA.
Claim 15
Independent Claim
86 words
A method of replicating a heterologous RNA in a eucaryotic cell comprising the steps of: a. isolating plasmid KDI-25 from an E. coli culture having ATCC accession number 53426; b. inserting heterologous DNA into the BalI site of plasmid KDI-25 to create a chimeric plasmid, c. transcribing the chimeric plasmid, into chimeric RNA; d. transfecting a eucaryotic cell with the chimeric RNA in the presence of helper virus; and e. growing the transfected eucaryotic cells under conditions which promote the replication of Sindbis virus DI RNA.
Claim 16
Independent Claim
116 words
A method of preparing a vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, the method comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising DNA encoding heterologous protein between nucleotides 241 to 1928 to create a chimeric DNA molecule; c. transcribing the chimeric DNA molecule into a chimeric RNA molecule; and d. isolating the chimeric RNA molecule.
Claim 17
Independent Claim
116 words
A method of preparing a vector consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA, and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, the method comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising DNA encoding heterologous protein between nucleotides 241 to 1928 to create a chimeric DNA molecule; c. transcribing the chimeric DNA molecule into a chimeric RNA molecule; and d. isolating the chimeric RNA molecule.
Claim 18
Independent Claim
116 words
A method of producing a heterologous protein in a eucaryotic cell comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising DNA sequences encoding the heterologous protein between nucleotides 241 and 1928; c. transcribing the first DNA and the second DNA contained therein as a continuous transcript; d. transfecting a eucaryotic cell with the continuous transcript in the presence of helper virus; and e. growing the transfected eucaryotic cell under conditions which provide for the expression of Sindbis virus DI RNA.
Claim 19
Independent Claim
116 words
A method of producing a heterologous protein in a eucaryotic cell comprising the steps of: a. cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising DNA sequences encoding the heterologous protein between nucleotides 241 and 1928; c. transcribing the first DNA and the second DNA contained therein as a continuous transcript; d. transfecting a eucaryotic cell with the continuous transcript in the presence of helper virus; and e. growing the transfected eucaryotic cell under conditions which provide for the expression of Sindbis virus DI RNA.
Claim 20
Independent Claim
82 words
A method of producing heterologous protein in a eucaryotic cell which comprises expression of RNA, said RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon, followed by sequences encoding the heterologous protein to be produced in said cell, followed by a translation stop-signal codon and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, and recovering the resulting heterologous protein produced within said eucaryotic cell.
Claim 21
Independent Claim
82 words
A method of producing heterologous protein in a eucaryotic cell which comprises expression of RNA, said RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, heterologous RNA comprising a translation start-signal codon, followed by sequences encoding the heterologous protein to be produced in said cell, followed by a translation stop-signal codon and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, and recovering the resulting heterologous protein produced within said eucaryotic cell.
Claim 22
Dependent Claim
7 words
Plasmid KDI-25 having ATCC accession number 53426.
Claim 23
Dependent Claim
7 words
Plasmid KDI-25 having ATCC accession number 53426.
Claim 24
Independent Claim
103 words
A method for genetically modifying a Sindbis virus comprising the steps of: a. Cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising heterologous DNA between nucleotides 241 and 1928; c. transcribing the first and second DNA molecules as a continuous transcript; d. transfecting a host cell with the continuous transcript in the presence of helper virus; and e. isolating Sindbis DI particles comprising Sindbis DI RNA having inserted therein heterologous RNA.
Claim 25
Independent Claim
103 words
A method for genetically modifying a Sindbis virus comprising the steps of: a. Cloning a first DNA molecule comprising a cDNA of a Sindbis virus DI RNA molecule downstream from a promoter able to cause transcription by a DNA dependent RNA polymerase; b. substituting into the Sindbis virus cDNA a second DNA molecule comprising heterologous DNA between nucleotides 241 and 1928; c. transcribing the first and second DNA molecules as a continuous transcript; d. transfecting a host cell with the continuous transcript in the presence of helper virus; and e. isolating Sindbis DI particles comprising Sindbis DI RNA having inserted therein heterologous RNA.
Claim 26
Dependent Claim
79 words
An infectious Sindbis defective interfering (DI) alphavirus particle containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, at least one protein coding sequence from a heterologous gene and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, permitting replication and packaging in the presence of helper virus such that said infectious Sindbis DI alphavirus is capable upon infection of a host cell of expressing said protein coding sequence.
Claim 27
Dependent Claim
79 words
An infectious Sindbis defective interfering (DI) alphavirus particle containing RNA consisting essentially of, in sequence, Sindbis virus DI RNA nucleotides 1 to 241, at least one protein coding sequence from a heterologous gene and Sindbis virus DI RNA nucleotides 1928 to 2314, followed by a poly A tail, permitting replication and packaging in the presence of helper virus such that said infectious Sindbis DI alphavirus is capable upon infection of a host cell of expressing said protein coding sequence.
References Cited (Backward Citations)
US4719177A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-24 | 1995-08-26 | 1996-02-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-24 | 1999-08-26 | 2000-02-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-24 | 2003-08-26 | 2004-02-25 | $7700.00 | Window Closed / Lapsed |